This updated administration of Udenyca allows patients to receive this treatment in the office or at home. A single-dose, prefilled autoinjector version of Udenyca (pegfilgrastim-cbqv) has been ...

Udenyca (pegfilgrastim-cbqv) is a brand-name drug that’s prescribed for decreasing the risk of infection in people receiving chemotherapy for non-myeloid cancer and more. Udenyca comes as an injection ...

“Those independent patients, with families and busy lifestyles, or those who just have a hard time coming back to the office the day after chemotherapy—that’s who is really going to benefit from the ...

Coherus launches Udenyca wearable injector device The on-body device delivers Udenyca, a biosimilar pegfilgrastim administered the day after chemotherapy to decrease the incidence of infection as ...

Good day and thank you for standing by. Welcome to the Coherus Biosciences Q1 2023 Earnings Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like ...

Credit: Coherus BioSciences. Training should be provided to patients and caregivers on how to appropriately administer Udenyca via the prefilled autoinjector. Udenyca ® (pegfilgrastim-cbqv), a ...

If you’re receiving cancer treatment that increases your risk of infections, your doctor might suggest Udenyca as a treatment option. It’s a prescription drug used to prevent neutropenia (a low level ...